Sens. Van Hollen, Warner, Markey Call to Fairly Evaluate Alzheimer's Treatments
March 23, 2022
March 23, 2022
WASHINGTON, March 23 -- Sen. Chris Van Hollen, D-Maryland, issued the following news release:
U.S. Senator Chris Van Hollen (D-Md.) joined Senators Mark R. Warner (D-Va.) and Ed Markey (D-Mass.) alongside Senator Debbie Stabenow (D-Mich.) in raising concerns with the Centers for Medicare and Medicaid Services (CMS) regarding its draft National Coverage Determination (NCD) decision memo for the drug Aduhelm and other similar Alzheimer's treatments.
In the January 11 . . .
U.S. Senator Chris Van Hollen (D-Md.) joined Senators Mark R. Warner (D-Va.) and Ed Markey (D-Mass.) alongside Senator Debbie Stabenow (D-Mich.) in raising concerns with the Centers for Medicare and Medicaid Services (CMS) regarding its draft National Coverage Determination (NCD) decision memo for the drug Aduhelm and other similar Alzheimer's treatments.
In the January 11 . . .
